US 11708413
Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates
granted A61KA61K2039/505A61K47/6803
Quick answer
US patent 11708413 (Anti-CD74 antibody conjugates, compositions comprising anti-CD74 antibody conjugates and methods of using anti-CD74 antibody conjugates) held by Sutro Biopharma, Inc. expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sutro Biopharma, Inc.
- Grant date
- Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/505, A61K47/6803, A61K47/68031, A61K47/68033